Givaudan | GIVN - Operating Profit

Stock Price
2,810.00
Daily Change
-10.00 -0.35%
Monthly
4.00%
Yearly
-28.26%
Q2 Forecast
2,758.85

Givaudan reported CHF610M in Operating Profit for its fiscal semester ending in December of 2025.





Operating Profit Change Date
Air Liquide EUR 2.84B 6.65B Dec/2025
Akzo Nobel EUR 254M 37M Mar/2026
Anheuser-Busch USD 4.2B 192M Sep/2025
Arkema EUR 25M 82M Dec/2025
Associated British Foods GBP 620M 205M Jun/2026
BASF EUR -175M 668M Dec/2025
Bayer EUR 1.11B 1.65B Dec/2025
Beiersdorf EUR 504M 312M Dec/2025
British American Tobacco GBP 5B 86M Dec/2025
Covestro EUR -324M 5.72B Dec/2025
Croda International GBP 113M 53.55M Dec/2024
Danone EUR 1.86B 48M Dec/2025
Diageo GBP 3.26B 1.92B Dec/2025
Fresenius EUR 713M 139M Dec/2025
Fresenius Medical Care EUR 663M 213.06M Dec/2025
Givaudan CHF 610M 149M Dec/2025
Heineken EUR 1.97B 40M Dec/2025
Henkel EUR 1.42B 187M Dec/2025
International Flavors Fragrances USD 113M 129M Dec/2025
Johnson Matthey GBP 142M 89M Dec/2025
Kerry EUR 463.5M 94.2M Dec/2024
Lonza CHF 673M 243M Jun/2025
L'Oréal EUR 3.92B 824.8M Dec/2025
Merck EUR 474M 738M Dec/2025
Nestle CHF 6.84B 293M Dec/2025
Pernod Ricard EUR 1.61B 644M Dec/2025
Reckitt Benckiser GBP 747M 92M Dec/2024
SGS CHF 253M 45.5M Dec/2024
Sika AG CHF 724.9M 73.2M Dec/2025
Solvay EUR 60M 78M Dec/2025
Tate & Lyle GBP 129M 0 Dec/2025
Umicore EUR 304.3M 959.85M Jun/2025
Victrex GBP 22.9M 1.1M Dec/2025